Aims and scope
Heart is an international peer reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Topics cover the breadth of cardiovascular disease with special emphasis on valve disease, congenital heart disease, and inherited cardiovascular conditions as well as coronary disease, heart failure, arrhythmias, imaging, epidemiology, global health, genomics and translational science.
Each issue contains original scientific articles with accompanying editorials, reviews of recent advances in clinical and translational cardiovascular science, an extensive continuing professional education section (Education in Heart), the Image Challenge series of image-based cases with multiple choice questions, and JournalScan summarizing important papers published in other journals.
Heart is an official journal of the British Cardiovascular Society and is endorsed by the following societies:
- British Cardiovascular Intervention Society
- British Congenital Cardiac Association
- British Society of Cardiovascular Imaging
- British Society of Cardiovascular Magnetic Resonance
- British Society for Cardiovascular Research
- Irish Cardiac Society
Heart is co-owned by the British Cardiovascular Society and BMJ.
Time from Submission to First Decision
Time from Acceptance to Publication
16 days (online)
104 days (print)
Index Medicus (Medline), ISI Current Contents (Web of Science), EMBASE, Google Scholar
For all contact information please refer to the contact us page.
Please refer to the Instructions for authors
Rights and permissions
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.